New
Pharmacelera
The AI engine Fit Assessment
BetaThe company will be attending the 2024 Health Tech Forward Event
Blurb
Quantum-Mechanics (QM) and Machine Learning (ML) Drug Discovery
HQ Location
Barcelona (Spain)
Founded
2015
Employees
11 - 50
Total funding raised
$4.04M
Last Funding Event
Seed, $1.74M, April 1, 2023
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Developer of a drug discovery platform designed to explore large and diverse chemical spaces. The company's platform uses a 3D representation of molecules based on electrostatic, steric and hydrophobic interaction fields derived from semi-empirical quantum-mechanics calculations, enabling bioinformaticians and medicinal chemists to obtain results using benchmarked technology and boost their drug discovery projects.